B. Ebert

发表

Pharmacological Characterization of Agonists at δ-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of γ2

Signe í Stórustovu, B. Ebert, Bjarke Ebert, 2006, Journal of Pharmacology and Experimental Therapeutics.

Analogues of homoibotenic acid show potent and selective activity following sensitisation by quisqualic acid.

U. Madsen, B. Ebert, H. Vestergaard, 2004, European journal of pharmacology.

Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone: evidence for A29 as a non-competitive NMDA receptor antagonist.

B. Ebert, C. Thorkildsen, S. Andersen, 1998, Pharmacology & toxicology.

Aryl and cycloalkyl analogues of AMPA: synthetic, pharmacological and stereochemical aspects.

P. Krogsgaard‐Larsen, E. Falch, B. Ebert, 1998, Bioorganic & medicinal chemistry.

Dextropropoxyphene acts as a noncompetitive N-methyl-D-aspartate antagonist.

A. Dickenson, B. Ebert, S. Andersen, 1998, Journal of pain and symptom management.

Excitatory amino-acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1997 .

Excitatory amino acid receptor antagonists: resolution, absolute stereochemistry, and pharmacology of (S)- and (R)-2-amino-2-(5-tert-butyl-3-hydroxyisoxazol-4-yl)acetic acid (ATAA).

P. Krogsgaard‐Larsen, K. Frydenvang, U. Madsen, 1997, Chirality.

Bioisosterically modified dipeptide excitatory amino acid receptor antagonists containing 3-oxygenated isothiazole ring systems.

P. Krogsgaard‐Larsen, J. Jaroszewski, B. Frølund, 1997, Bioorganic & medicinal chemistry.

Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists.

P. Krogsgaard‐Larsen, B. Bang-Andersen, U. Madsen, 1996, Journal of medicinal chemistry.

Excitatory amino acids. Synthesis of (RS)-2-amino-3-(5-cyclopropyl-3-hydroxyisoxazol-4-yl)propionic acid, a new potent and specific AMPA receptor agonist

P. Krogsgaard‐Larsen, E. Falch, B. Ebert, 1995 .

The non-depolarizing D-form of bromohomoibotenic acid enhances depolarizations evoked by the L-form or quisqualate.

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1993, European journal of pharmacology.

Excitatory amino acid receptor atagonists: synthesis and pharmacology of 3-(carboxymethoxy)isoxazoles derived from AMPA

P. Krogsgaard‐Larsen, T. B. Rasmussen, U. Madsen, 1993 .

Enzymatic resolution of AMPA by use of α-chymotrypsin

D. R. Curtis, P. Krogsgaard‐Larsen, U. Madsen, 1993 .

Synthesis and pharmacology of (RS)-2-amino-3-(3-hydroxy-5-trifluoromethyl-4-isoxazolyl)propionic acid, a potent AMPA receptor agonist

E. Wong, P. Krogsgaard‐Larsen, U. Madsen, 1992 .

Effects of GABAA receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions

U. Kristiansen, B. Ebert, S. L. Hansen, 2001, British journal of pharmacology.

Functional Characterization of the 1,5-Benzodiazepine Clobazam and Its Major Active Metabolite N-Desmethylclobazam at Human GABAA Receptors Expressed in Xenopus laevis Oocytes

A. A. Jensen, B. Ebert, H. Jensen, 2015, PloS one.

Synthesis and pharmacology of the baclofen homologues 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorophenyl)pentanoic acid.

P. Krogsgaard‐Larsen, B. Ebert, B. Nielsen, 1999, Journal of medicinal chemistry.

5-Substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma-aminobutyric acid(C) receptor agonists.

T. Liljefors, U. Kristiansen, P. Krogsgaard‐Larsen, 2007, Journal of Medicinal Chemistry.

Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].

K. Bogeso, P. Krogsgaard‐Larsen, B. Ebert, 1994, Journal of medicinal chemistry.

Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.

J. Greenwood, P. Krogsgaard‐Larsen, R. Clausen, 2005, Journal of medicinal chemistry.

Bioisosteric determinants for subtype selectivity of ligands for heteromeric GABA(A) receptors.

J. Kehler, P. Krogsgaard‐Larsen, M. Mortensen, 2001, Bioorganic & medicinal chemistry letters.

GABA(A) receptor ligands and their therapeutic potentials.

T. Liljefors, U. Kristiansen, P. Krogsgaard‐Larsen, 2002, Current topics in medicinal chemistry.

A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.

S. Nakanishi, P. Krogsgaard‐Larsen, H. Bräuner‐Osborne, 1996, Journal of medicinal chemistry.

Serotonin1A receptor autoradiography during alcohol-withdrawal kindling

R. Hemmingsen, N. Diemer, S. Haugbol, 1997, Psychopharmacology.

Characterization of a new AMPA receptor radioligand, [3H]2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid.

P. Krogsgaard‐Larsen, N. Diemer, U. Madsen, 1999, European journal of pharmacology.

The opioid ketobemidone has a NMDA blocking effect

A. Reeve, A. Dickenson, B. Ebert, 1996, Pain.

Structure and pharmacology of 4,5,6,7-tetrahydroisothiazolo[5,4-c]pyridin-3-ol (Thio-THIP), an agonist/antagonist at GABAA receptors

J. Kemp, U. Kristiansen, P. Krogsgaard‐Larsen, 1997 .

Lack of generalisation between the GABAA receptor agonist, gaboxadol, and allosteric modulators of the benzodiazepine binding site in the rat drug discrimination procedure

C. Sánchez, B. Ebert, S. Michelsen, 2007, Psychopharmacology.

Synthesis of 3‐Hydroxy‐ and 3‐Carboxy‐Δ2‐isoxazoline Amino Acids and Evaluation of Their Interaction with GABA Receptors and Transporters

A. Pinto, L. Tamborini, P. Conti, 2006 .

Benzodiazepine receptor agonists and insomnia: Is subtype selectivity lost in translation?

K. Wafford, B. Ebert, 2006 .

Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance.

C. Sánchez, B. Ebert, S. Michelsen, 2003, European journal of pharmacology.

Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists.

L. Christrup, B. Ebert, C. Thorkildsen, 1998, Biochemical pharmacology.

Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.

K. Bogeso, P. Krogsgaard‐Larsen, B. Bang-Andersen, 1997, Journal of medicinal chemistry.

Ligands for the GABAA receptor complex

U. Kristiansen, P. Krogsgaard‐Larsen, B. Frølund, 2001 .

GABAA and GABAB receptor agonists, partial agonists, antagonists and modulators: design and therapeutic prospects

U. Kristiansen, P. Krogsgaard‐Larsen, K. Frydenvang, 1997 .

GABAA Receptor Agonists, Partial Agonists, and Antagonists

P. Krogsgaard‐Larsen, B. Frølund, B. Ebert, 1997 .

Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord

P. Krogsgaard‐Larsen, B. Ebert, S. Andersen, 1995, Neuroscience Letters.

Characterization of GABAA receptor ligands in the rat cortical wedge preparation: evidence for action at extrasynaptic receptors?

B. Frølund, M. Mortensen, Signe í Stórustovu, 2002, British journal of pharmacology.

4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships.

J. Kehler, T. Liljefors, P. Krogsgaard‐Larsen, 2007, Journal of medicinal chemistry.

Synthesis and binding affinity of new muscarinic ligands structurally related to oxotremorine

P. Conti, C. Dallanoce, B. Ebert, 1997 .

Syntheses of novel piperidin-4-ylphosphinic acid, and piperidin-4-ylphosphonic acid analogues of the inhibitory neurotransmitter 4-aminobutyric acid (GABA)

J. Kehler, P. Krogsgaard‐Larsen, B. Ebert, 1998 .

Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.

P. Krogsgaard‐Larsen, H. Bräuner‐Osborne, U. Madsen, 1998, Journal of medicinal chemistry.

Syntheses and GABA receptor binding properties of 4-amino-1-, 2-, and 3-hydroxybutylphosphinic acids

J. Kehler, P. Krogsgaard‐Larsen, B. Ebert, 1999 .

Activation of single heteromeric GABAA receptor ion channels by full and partial agonists

U. Kristiansen, P. Krogsgaard‐Larsen, T. Smart, 2004, The Journal of physiology.

Quantitative microdialysis using modified ultraslow microdialysis: Direct rapid and reliable determination of free brain concentrations with the MetaQuant technique

B. Westerink, B. Ebert, E. D. Lange, 2009, Journal of Neuroscience Methods.

Escitalopram versus citalopram: the surprising role of the R-enantiomer

K. Bogeso, C. Sánchez, C. Braestrup, 2004, Psychopharmacology.

Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.

T. Liljefors, P. Krogsgaard‐Larsen, B. Frølund, 2006, Journal of medicinal chemistry.

Design of excitatory amino acid receptor agonists, partial agonists and antagonists: ibotenic acid as a key lead structure

P. Krogsgaard‐Larsen, H. Bräuner‐Osborne, U. Madsen, 1996 .

Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.

D. R. Curtis, P. Krogsgaard‐Larsen, N. Diemer, 1991, Journal of medicinal chemistry.

Functional partial agonism at cloned human muscarinic acetylcholine receptors.

M. Brann, P. Krogsgaard‐Larsen, E. Falch, 1996, European journal of pharmacology.

Clobazam and Its Active Metabolite N-desmethylclobazam Display Significantly Greater Affinities for α2- versus α1-GABAA–Receptor Complexes

B. Ebert, H. Jensen, Deborah Lee, 2014, PloS one.

Role of 5-HT3 Receptors in the Antidepressant Response

C. Sánchez, C. Bétry, N. Haddjeri, 2011, Pharmaceuticals.

Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.

J. Nielsen, B. Ebert, K. Frederiksen, 2006, European journal of pharmacology.

Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists.

P. Krogsgaard‐Larsen, B. Bang-Andersen, U. Madsen, 1996, Journal of medicinal chemistry.

Modulation of AMPA receptor function in relation to glutamatergic abnormalities in Alzheimer's disease.

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Excitatory amino acid receptors: Multiplicity and ligand specificity of the NMDA and AMPA receptor subtypes

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1992 .

Novel Class of Amino Acid Antagonists at Non‐N‐methyl‐D‐aspartic Acid Excitatory Amino Acid Receptors. Synthesis, in vitro and in vivo Pharmacology, and Neuroprotection.

D. R. Curtis, P. Krogsgaard‐Larsen, N. Diemer, 1991 .

Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors.

R. Mckernan, P. Krogsgaard‐Larsen, B. Ebert, 1997, Molecular pharmacology.

Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.

F. M. Borgbjerg, B. Ebert, S. Mikkelsen, 1997, European journal of pharmacology.

Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.

Signe í Stórustovu, B. Ebert, Bjarke Ebert, 2006, The Journal of pharmacology and experimental therapeutics.

Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA.

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1999, European journal of pharmacology.

NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicity.

P. Krogsgaard‐Larsen, J. Ferkany, U. Madsen, 1990, European journal of pharmacology.

Distinct activities of GABA agonists at synaptic‐ and extrasynaptic‐type GABAA receptors

T. Smart, K. Wafford, M. Mortensen, 2010, The Journal of physiology.

The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT3 receptor expressing interneurons: An in vitro study in rat hippocampus slices

J. Nielsen, Charles R. Yang, C. Sánchez, 2017, Brain Research.

AMPA receptor agonists: resolution, configurational assignment, and pharmacology of (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4-yl]-propionic acid (2-Py-AMPA).

P. Krogsgaard‐Larsen, E. Falch, B. Ebert, 1997, Chirality.

Activity of novel 4-PIOL analogues at human α1β2γ2S GABAA receptors—correlation with hydrophobicity

T. Liljefors, P. Krogsgaard‐Larsen, B. Frølund, 2002 .

Clobazam and Its Active Metabolite, N-Desmethylclobazam, Are Partial Benzodiazepine Receptor Agonists at Cloned GABAA Receptors Expressed in Xenopus leavis Oocytes (P05.085)

B. Ebert, H. Jensen, H. Hammer, 2012 .

Functional Characterization of GABAA Receptor Ligands In Vitro

S. Thompson, K. Wafford, Signe í Stórustovu, 2004 .

Triton X-100 inhibits agonist-induced currents and suppresses benzodiazepine modulation of GABA(A) receptors in Xenopus oocytes.

T. Werge, B. Ebert, D. Klaerke, 2009, Biochimica et biophysica acta.

Gaboxadol--a new awakening in sleep.

K. Wafford, B. Ebert, Keith A Wafford, 2006, Current opinion in pharmacology.

Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.

J. Kemp, P. Whiting, P. Krogsgaard‐Larsen, 1994, Molecular pharmacology.

GABA Site Agonist Gaboxadol Induces Addiction-Predicting Persistent Changes in Ventral Tegmental Area Dopamine Neurons But Is Not Rewarding in Mice or Baboons

E. Korpi, E. Vashchinkina, T. Aitta-aho, 2012, The Journal of Neuroscience.

Pharmacology of GABA(A) receptors exhibiting different levels of spontaneous activity.

K. Wafford, M. Mortensen, B. Ebert, 2003, European journal of pharmacology.

Postnatal development and kinetics of [3H]gaboxadol binding in rat brain: In vitro homogenate binding and quantitative autoradiography

P. Brust, B. Ebert, P. Hutson, 2007, Brain Research.

Correlation of the expression of kainate receptor subtypes to responses evoked in cultured cortical and spinal cord neurones

J. Lambert, B. Ebert, J. Egebjerg, 2002, Brain Research.

GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.

T. Liljefors, P. Krogsgaard‐Larsen, B. Frølund, 2004, Biochemical pharmacology.

Plasma and CNS concentrations of Gaboxadol in rats following subcutaneous administration.

B. Ebert, T. Cremers, 2007, European journal of pharmacology.

Treating insomnia: Current and investigational pharmacological approaches.

K. Wafford, S. Deacon, Stephen Deacon, 2006, Pharmacology & therapeutics.

The orthosteric GABAA receptor ligand Thio‐4‐PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors

U. Kristiansen, N. O. Dalby, J. Cryan, 2013, British journal of pharmacology.

Design, synthesis and pharmacology of model compounds for indirect elucidation of the topography of AMPA receptor sites

P. Krogsgaard‐Larsen, B. Frølund, U. Madsen, 1993 .

Extrasynaptic GABAA channels activated by THIP are modulated by diazepam in CA1 pyramidal neurons in the rat brain hippocampal slice

B. Birnir, B. Ebert, C. Lindquist, 2003, Molecular and Cellular Neuroscience.

Selective GABA Transporter Inhibitors Tiagabine and EF1502 Exhibit Mechanistic Differences in Their Ability to Modulate the Ataxia and Anticonvulsant Action of the Extrasynaptic GABAA Receptor Agonist Gaboxadol

A. Schousboe, P. Krogsgaard‐Larsen, H. White, 2011, Journal of Pharmacology and Experimental Therapeutics.

The δ Subunit of γ-Aminobutyric Acid Type A Receptors Does Not Confer Sensitivity to Low Concentrations of Ethanol

R. Harris, J. Lambert, K. Wafford, 2006, Journal of Pharmacology and Experimental Therapeutics.

Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time

K. Wafford, B. Ebert, 2008, Nature Reviews Drug Discovery.

R‐citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter

C. Sánchez, P. Pörzgen, Signe í Stórustovu, 2004, British journal of pharmacology.

P. Krogsgaard‐Larsen, B. Frølund, B. Ebert, 2003, Bioorganic & medicinal chemistry.

Upregulation of glutamate receptor subtypes during alcohol withdrawal in rats.

S. Haugbol, B. Ebert, J. Ulrichsen, 2005, Alcohol and alcoholism.

The delta subunit of gamma-aminobutyric acid type A receptors does not confer sensitivity to low concentrations of ethanol.

R. Harris, J. Lambert, K. Wafford, 2006, The Journal of pharmacology and experimental therapeutics.

Glutamate and benzodiazepine receptor autoradiography in rat brain after repetition of alcohol dependence

R. Hemmingsen, P. Allerup, N. Diemer, 1996, Psychopharmacology.

The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.

C. Sánchez, C. Bétry, N. Haddjeri, 2013, The international journal of neuropsychopharmacology.

Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures

B. Kristensen, J. Noraberg, J. Zimmer, 1999, Brain Research.

Modulators of the GABAA receptor: Novel therapeutic prospects

C. Thomsen, B. Ebert, 2001 .

Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder.

S. Kasper, K. Larsen, B. Ebert, 2012, The international journal of neuropsychopharmacology.

P.2.d.012 Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder

S. Kasper, K. Larsen, B. Ebert, 2011, European Neuropsychopharmacology.

Discontinued drugs 2007: central and peripheral nervous system drugs

B. Ebert, 2009 .

Studies of the antagonist actions of (RS)‐2‐amino‐3‐[5‐tert‐butyl‐3‐(phosphonomethoxy)‐4‐isoxazolyl]propionic acid (ATPO) on non‐NMDA receptors in cultured rat neurones

J. Lambert, U. Madsen, B. Ebert, 1998, British journal of pharmacology.

Identification of a novel NMDA receptor in rat cerebellum.

E. Wong, P. Krogsgaard‐Larsen, B. Ebert, 1991, European journal of pharmacology.

Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice

R. Hen, C. Repérant, C. Sánchez, 2013, Neuropharmacology.

A tetrazolyl-substituted subtype-selective AMPA receptor agonist.

J. Greenwood, P. Krogsgaard‐Larsen, J. Kastrup, 2007, Journal of medicinal chemistry.

Positive modulation of δ-subunit containing GABAA receptors in mouse neurons

N. O. Dalby, K. Jensen, B. Ebert, 2012, Neuropharmacology.

Zinc changes AMPA receptor properties: Results of binding studies and patch clamp recordings

C. Parsons, B. Ebert, E. Mutschler, 1996, Neuropharmacology.

Equilibrium binding characteristics of [3H]thiomuscimol

P. Krogsgaard‐Larsen, N. Diemer, B. Frølund, 1999, Neurochemistry International.

N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.

P. Krogsgaard‐Larsen, K. Frydenvang, U. Madsen, 1996, Journal of medicinal chemistry.

Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1992, Journal of medicinal chemistry.

Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1994, Neurochemistry International.

Discontinued drugs 2007: central and peripheral nervous system drugs.

B. Ebert, 2009, Expert Opinion on Investigational Drugs.

Excitatory amino acid receptor ligands: asymmetric synthesis, absolute stereochemistry and pharmacology of (R)- and (S)-homoibotenic acid.

P. Krogsgaard‐Larsen, U. Madsen, B. Ebert, 1995, Bioorganic & medicinal chemistry.

Synthesis and receptor binding of 5‐amino[3H]2methyl‐3‐isothiazolol ([3H]thiomuscimol), a specific GABAa agonist photoaffinity label

P. Krogsgaard‐Larsen, B. Frølund, B. Ebert, 1995 .

Synthesis and pharmacology of seleninic acid analogues of the inhibitory neurotransmitter gamma-aminobutyric acid.

J. Kehler, P. Krogsgaard‐Larsen, N. Stuhr-Hansen, 2000, Organic letters.

Thiomuscimol, a new photoaffinity label for the GABAA receptor.

P. Krogsgaard‐Larsen, B. Ebert, M. Witt, 1995, European journal of pharmacology.

AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.

P. Krogsgaard‐Larsen, J. Jaroszewski, B. Frølund, 1997, Journal of medicinal chemistry.

Gaboxadol: in vitro interaction studies with benzodiazepines and ethanol suggest functional selectivity.

Signe í Stórustovu, B. Ebert, 2003, European journal of pharmacology.

Gaboxadol — a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing

C. Sánchez, B. Ebert, T. Cremers, 2008, Pharmacology Biochemistry and Behavior.

A New Highly Selective Metabotropic Excitatory Amino Acid Agonist: 2‐ Amino‐4‐(3‐hydroxy‐5‐methylisoxazol‐4‐yl)butyric Acid.

S. Nakanishi, P. Krogsgaard‐Larsen, B. Ebert, 1996 .